v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022   48,051        
Beginning balance at Dec. 31, 2022 $ 1,031,569 $ 48 $ 1,325,524 $ (295,117) $ 1,370 $ (256)
Beginning balance (in shares) at Dec. 31, 2022           14
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options to purchase common stock (in shares)   131        
Exercise of options to purchase common stock 4,172   4,172      
Vesting of restricted stock units (in shares)   58        
Vesting of restricted stock units (859)   (859)      
Share-based compensation expense 21,118   21,118      
Purchase of capped call options (66,211)   (66,211)      
Foreign currency translation (2,329)       (2,329)  
Net income (loss) (48,904)     (48,904)    
Ending balance (in shares) at Sep. 30, 2023   48,240        
Ending balance at Sep. 30, 2023 938,556 $ 48 1,283,744 (344,021) (959) $ (256)
Ending balance (in shares) at Sep. 30, 2023           14
Beginning balance (in shares) at Jun. 30, 2023   48,185        
Beginning balance at Jun. 30, 2023 937,784 $ 48 1,275,510 (336,855) (663) $ (256)
Beginning balance (in shares) at Jun. 30, 2023           14
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options to purchase common stock (in shares)   40        
Exercise of options to purchase common stock 1,111   1,111      
Vesting of restricted stock units (in shares)   15        
Vesting of restricted stock units (9)   (9)      
Share-based compensation expense 7,132   7,132      
Foreign currency translation (296)       (296)  
Net income (loss) (7,166)     (7,166)    
Ending balance (in shares) at Sep. 30, 2023   48,240        
Ending balance at Sep. 30, 2023 $ 938,556 $ 48 1,283,744 (344,021) (959) $ (256)
Ending balance (in shares) at Sep. 30, 2023           14
Beginning balance (in shares) at Dec. 31, 2023 48,263 48,277        
Beginning balance at Dec. 31, 2023 $ 953,454 $ 48 1,282,984 (328,731) (591) $ (256)
Beginning balance (in shares) at Dec. 31, 2023 14         14
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options to purchase common stock (in shares) 196 196        
Exercise of options to purchase common stock $ 5,516   5,516      
Vesting of restricted stock units (in shares)   78        
Vesting of restricted stock units (2,241)   (2,241)      
Share-based compensation expense 35,508   35,508      
Foreign currency translation 407       407  
Net income (loss) $ 28,803     28,803    
Ending balance (in shares) at Sep. 30, 2024 48,537 48,551        
Ending balance at Sep. 30, 2024 $ 1,021,447 $ 48 1,321,767 (299,928) (184) $ (256)
Ending balance (in shares) at Sep. 30, 2024 14         14
Beginning balance (in shares) at Jun. 30, 2024   48,493        
Beginning balance at Jun. 30, 2024 $ 995,804 $ 48 1,308,623 (311,823) (788) $ (256)
Beginning balance (in shares) at Jun. 30, 2024           14
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options to purchase common stock (in shares)   51        
Exercise of options to purchase common stock 1,320   1,320      
Vesting of restricted stock units (in shares)   7        
Vesting of restricted stock units (82)   (82)      
Share-based compensation expense 11,906   11,906      
Foreign currency translation 604       604  
Net income (loss) $ 11,895     11,895    
Ending balance (in shares) at Sep. 30, 2024 48,537 48,551        
Ending balance at Sep. 30, 2024 $ 1,021,447 $ 48 $ 1,321,767 $ (299,928) $ (184) $ (256)
Ending balance (in shares) at Sep. 30, 2024 14         14